trihexyphenidyl has been researched along with Child Development Deviations in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Benzhexol, glycopyrrolate, and scopolamine reduce drooling, but improvement is offset by adverse side effects." | 3.96 | Anticholinergic medications for reducing drooling in children with developmental disability. ( Guzys, AT; Reddihough, DS; Reid, SM; Westbury, C, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reid, SM | 1 |
| Westbury, C | 1 |
| Guzys, AT | 1 |
| Reddihough, DS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Single-Dose Pharmacokinetics of Atropine Oral Gel in Healthy Adults[NCT05164367] | Early Phase 1 | 10 participants (Anticipated) | Interventional | 2022-10-01 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for trihexyphenidyl and Child Development Deviations
| Article | Year |
|---|---|
Anticholinergic medications for reducing drooling in children with developmental disability.
Topics: Adolescent; Child; Child, Preschool; Cholinergic Antagonists; Developmental Disabilities; Female; Gl | 2020 |